COSCIENS Biopharma (CSCI.TO) closed the second tranche of a non-brokered private placement of the 15% unsecured convertible debentures, raising $4.4 million, it said in a statement late Wednesday.
Together with the first closing, the company raised $10.7 million. COSCIENS anticipates closing one or more additional tranches in the coming weeks, it said.
The company's shares last traded Sept. 15, closing at CA$7.45 on the Toronto Stock Exchange.